BAC
Bank of America Corporation
BAC has the edge over FITB overall, supported by stronger valuation and stronger fundamentals.
FITB
Fifth Third Bancorp
FITB's outlook is improving despite an expensive valuation.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
FITB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| N/A | |
| N/A |
FITB's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like FITB.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over FITB in the historical PE scenario, which offers more potential upside but is not a forecast.
FITB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.1x | $26.42 | -51% |
| Forward | 11x | $53.90 | — |
| Fair | 12x | $34.61 | -36% |
| Expensive | 15x | $42.99 | -20% |
| Current | 19x | $53.90 | — |
Historical ranges are pointers, not guarantees.
FITB's PE is in its expensive range at 19x. If earnings grow as analysts expect, today's price would be 11x next year's earnings, in its fair range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
FITB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for FITB, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over FITB on earnings, with more consistent year-over-year improvement.
FITB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.73 | +63% |
| Q3 2026 | $2.91 | -13% |
| Q2 2026 | $2.92 | -9.3% |
| Q1 2026 | $2.97 | -5.7% |
| Q4 2025 | $3.53 | +12% |
| Q3 2025 | $3.35 | +12% |
| Q2 2025 | $3.22 | +2.9% |
| Q1 2025 | $3.15 | +0.3% |
| Q4 2024 | $3.14 | -2.5% |
FITB earned $2.91 per share over the past year, down 13% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over FITB on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
FITB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.3B | +43% |
| Q2 2026 | $3.3B | +46% |
| Q1 2026 | $2.8B | +33% |
| Q4 2025 | $2.3B | +7.8% |
| Q3 2025 | $2.3B | +7.9% |
| Q2 2025 | $2.2B | +7.8% |
| Q1 2025 | $2.1B | +1.8% |
| Q4 2024 | $2.2B | +0.5% |
FITB's revenue has grown year over year for eight quarters in a row: $3.3B last quarter, up 43% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -2.6 points |
| Q2 2026 | 32% | -4.4 points |
| Q1 2026 | 7.3% | -23 points |
| Q4 2025 | 39% | +3.8 points |
| Q3 2025 | 36% | +2.2 points |
| Q2 2025 | 36% | -0.7 points |
| Q1 2025 | 31% | -0.8 points |
| Q4 2024 | 35% | +5.2 points |
FITB has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
FITB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $651M | -27% |
| Q2 2026 | $2.6B | +125% |
| Q1 2026 | -$1.3B | -212% |
| Q4 2025 | $765M | +$1B |
| Q3 2025 | $886M | -49% |
| Q2 2025 | $1.2B | +98% |
| Q1 2025 | $1.1B | +248% |
| Q4 2024 | -$246M | -113% |
FITB's free cash flow was $2.8B over the past year, down 4.6% from the year before. Free cash flow isn't a meaningful measure for financial services companies like FITB.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over FITB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
FITB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +1.1M shares |
| 1 year | +36% | +243M shares |
| 3 years | +34% | +231M shares |
| 5 years | +28% | +199M shares |
| Available history | +27% | +197M shares |
FITB has 917M diluted shares, up 36% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $300M |
| Q2 2025 | — |
| Q1 2025 | $225M |
| Q4 2024 | $300M |
FITB hasn't bought back shares in the past year.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
FITB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.5x | Elevated |
| Q2 2026 | 4.9x | High |
| Q1 2026 | 4.7x | High |
| Q4 2025 | 2.9x | Moderate |
| Q3 2025 | 3.0x | Moderate |
| Q2 2025 | 3.3x | Elevated |
| Q1 2025 | 3.4x | Elevated |
| Q4 2024 | 3.3x | Elevated |
FITB has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
FITB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.6 | Neutral |
| Stochastic | 47.3 | Neutral |
FITB's weekly RSI is 54 (neutral) and its Stochastic is 47 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over FITB on valuation relative to its sector.
FITB PE vs Financial Services Sector
| Metric | FITB | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 13x | 42% above |
| PE % | 94 | 63 | 31 pts above |
FITB is trading at 19x earnings, a 42% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
FITB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.2 | 3.2% above |
| 20 week MA | $54.6 | 1.2% below |
| 50 week MA | $51.5 | 4.6% above |
| 100 week MA | $46.5 | 16% above |
| 200 week MA | $40.1 | 34% above |
FITB has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
FITB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.9 | $27.6 | -11% |
| 2021 | $27.6 | $43.1 | +56% |
| 2022 | $43.1 | $32.4 | -25% |
| 2023 | $32.4 | $34.5 | +6.4% |
| 2024 | $34.5 | $42.9 | +24% |
| 2025 | $42.9 | $48.4 | +13% |
| 2026 YTD | $48.4 | $53.9 | +11% |
FITB has the edge over BAC on returns for 2026, with the stronger performance.